Prolight Diagnostics AB (publ)

NGM:PRLD Stock Report

Market Cap: SEK 108.1m

Prolight Diagnostics Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Prolight Diagnostics.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth37.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Is Prolight Diagnostics (NGM:PRLD) In A Good Position To Invest In Growth?

Jul 14
Is Prolight Diagnostics (NGM:PRLD) In A Good Position To Invest In Growth?

Companies Like Prolight Diagnostics (NGM:PRLD) Can Afford To Invest In Growth

Nov 07
Companies Like Prolight Diagnostics (NGM:PRLD) Can Afford To Invest In Growth

We Think Prolight Diagnostics (NGM:PRLD) Can Easily Afford To Drive Business Growth

Jul 06
We Think Prolight Diagnostics (NGM:PRLD) Can Easily Afford To Drive Business Growth

Companies Like Prolight Diagnostics (NGM:PRLD) Are In A Position To Invest In Growth

Mar 09
Companies Like Prolight Diagnostics (NGM:PRLD) Are In A Position To Invest In Growth

Prolight Diagnostics (NGM:PRLD) Is In A Good Position To Deliver On Growth Plans

Nov 24
Prolight Diagnostics (NGM:PRLD) Is In A Good Position To Deliver On Growth Plans

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Prolight Diagnostics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NGM:PRLD - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202425-140-38-19N/A
3/31/202424-137-42-28N/A
12/31/202324-135-40-25N/A
9/30/202331-22-48-18N/A
6/30/202333-17-46-16N/A
3/31/202336-16-48-18N/A
12/31/202235-12-36-9N/A
9/30/202215-17-26-16N/A
6/30/20229-14-17-11N/A
3/31/20223-9-4-3N/A
12/31/20210-7-7-7N/A
9/30/20210-7-14-14N/A
6/30/20211-6-10-7N/A
3/31/20211-4-16-7N/A
12/31/20201-4-21-7N/A
9/30/20201-4-211N/A
6/30/20200-3-29-4N/A
3/31/20200-5-29-6N/A
12/31/20190-4-28-4N/A
9/30/20190-5-29-6N/A
6/30/20190-6-35-7N/A
3/31/20190-6-34-2N/A
12/31/20180-6-35-3N/A
9/30/20181-5-31-2N/A
6/30/20180-4-190N/A
3/31/20180-3N/A-5N/A
12/31/20170-3N/A-5N/A
9/30/2017N/A-4N/AN/AN/A
6/30/2017N/A-3N/AN/AN/A
3/31/2017N/A-3N/AN/AN/A
12/31/2016N/A-2N/AN/AN/A
12/31/2015N/A-2N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if PRLD's forecast earnings growth is above the savings rate (1.2%).

Earnings vs Market: Insufficient data to determine if PRLD's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if PRLD's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if PRLD's revenue is forecast to grow faster than the Swedish market.

High Growth Revenue: Insufficient data to determine if PRLD's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if PRLD's Return on Equity is forecast to be high in 3 years time


Discover growth companies